Chemicals and Materials Specialty Polystyrene Resin Market New | Page 2
The specialty polystyrene resin market is projected to witness the highest growth in
the healthcare application.
Specialty polystyrene resins are adopted widely across the healthcare industry with
significant efforts to commercialize new medical polymers to meet the specification of
high-end use. The demand for specialty polystyrene resin in the healthcare market is
growing significantly owing to a significant upsurge in demand for medical labware,
pharmaceutical products, vacutainer trays, components for medical devices, and packaging
for essential medicines due to the increase in population. The demand for specialty
polystyrene resin is witnessing significant growth in all the regions due to the rapid
acceptance and adoption of polymers from product designing to final product
manufacturing.
APAC is expected to account for the largest market share during the forecast period.
APAC has emerged as the leading consumer and producer of specialty polystyrene resin.
The easy availability of low-cost labor and economical & accessible raw materials are
driving foreign investments, thereby increasing the production of specialty polystyrene
resin in the region. APAC is also the fastest-growing specialty polystyrene resin market.
The demand in APAC will further increase in the next five years because of the growing
furniture, appliances, and automotive industries in the developing countries.
For more information, download Free PDF brochure at,
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=38486801
The major vendors in the specialty polystyrene resin market are Sekisui Plastics Co., Ltd.
(Japan), NOVA Chemicals Corporation (Canada), Synthos (Poland), BASF SE (Germany),
SUNPOR KUNSTSTOFF GmbH (Austria), Atlas EPS (US), VERSALIS (Italy), SABIC (Saudi
Arabia), LG Chem, Ltd. (South Korea), BEWiSynbra Group AB (publ) (Sweden), Samsung
Fine Chemicals Co., Ltd (South Korea), Total S.A. (France), and Trinseo (US).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche
opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
Currently servicing 7500 customers worldwide including 80% of global Fortune 1000
companies as clients. Almost 75,000 top officers across eight industries worldwide approach
MarketsandMarkets™ for their painpoints around revenues decisions.